Unintentional combining enzalutamide with a moderate CYP2C8 inhibitor in a patient with metastatic castration-resistant prostate cancer: a case report
Verhulst, S. H., Boerrigter, E., Ras, S., van Erp, N. P., Hamberg, P.
Published in Cancer chemotherapy and pharmacology (01.04.2022)
Published in Cancer chemotherapy and pharmacology (01.04.2022)
Get full text
Journal Article
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients
Westerdijk, K., Krens, S. D., Steeghs, N., van der Graaf, W. T. A., Tjwa, E. T. T. L., Westdorp, H., Desar, I. M. E., van Erp, N. P.
Published in Cancer chemotherapy and pharmacology (01.04.2024)
Published in Cancer chemotherapy and pharmacology (01.04.2024)
Get full text
Journal Article
A pharmacological rationale for improved everolimus dosing in oncology and transplant patients
Heine, R., Erp, N. P., Guchelaar, H. J., Fijter, J. W., Reinders, M. E. J., Herpen, C. M., Burger, D. M., Moes, D. J. A. R.
Published in British journal of clinical pharmacology (01.07.2018)
Published in British journal of clinical pharmacology (01.07.2018)
Get full text
Journal Article
Use of incretin agents and risk of pancreatic cancer: a population-based cohort study
Knapen, L. M., van Dalem, J., Keulemans, Y. C., van Erp, N. P., Bazelier, M. T., De Bruin, M. L., Leufkens, H. G. M., Croes, S., Neef, C., de Vries, F., Driessen, J. H. M.
Published in Diabetes, obesity & metabolism (01.03.2016)
Published in Diabetes, obesity & metabolism (01.03.2016)
Get full text
Journal Article
Midazolam as a phenotyping probe to predict sunitinib exposure in patients with cancer
de Wit, D., Gelderblom, H., Sparreboom, A., den Hartigh, J., den Hollander, M., König-Quartel, J. M. C., Hessing, T., Guchelaar, H. J., van Erp, N. P.
Published in Cancer chemotherapy and pharmacology (2014)
Published in Cancer chemotherapy and pharmacology (2014)
Get full text
Journal Article
Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial
Guchelaar, H. J., Kapiteijn, E., Morreau, Hans, van Wezel, T., Gelderblom, Hans, van der Hoeven, J. J. M., van Erp, N. P., Links, T. P., de Wit, D., Schneider, T. C., van Eijk, R.
Published in International Journal of Endocrinology (01.01.2015)
Published in International Journal of Endocrinology (01.01.2015)
Get full text
Journal Article
Myelosuppression by sunitinib is flt-3 genotype dependent
van Erp, N P, Mathijssen, R H J, van der Veldt, A A, Haanen, J B, Reyners, A K L, Eechoute, K, Boven, E, Wessels, J A M, Guchelaar, H-J, Gelderblom, H
Published in British journal of cancer (24.08.2010)
Published in British journal of cancer (24.08.2010)
Get full text
Journal Article
Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study
Groenland, S.L., van Eerden, R.A.G., Westerdijk, K., Meertens, M., Koolen, S.L.W., Moes, D.J.A.R., de Vries, N., Rosing, H., Otten, H., Vulink, A.J.E., Desar, I.M.E., Imholz, A.L.T., Gelderblom, H., van Erp, N.P., Beijnen, J.H., Mathijssen, R.H.J., Huitema, A.D.R., Steeghs, N.
Published in Annals of oncology (01.10.2022)
Published in Annals of oncology (01.10.2022)
Get full text
Journal Article
Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer
Willemsen, A. E. C. A. B., Knapen, L. M., de Beer, Y. M., Brüggemann, R. J. M., Croes, S., van Herpen, C. M. L., van Erp, N. P.
Published in European journal of clinical pharmacology (01.04.2018)
Published in European journal of clinical pharmacology (01.04.2018)
Get full text
Journal Article
Everolimus pharmacokinetics and its exposure–toxicity relationship in patients with thyroid cancer
de Wit, D., Schneider, T. C., Moes, D. J. A. R., Roozen, C. F. M., den Hartigh, J., Gelderblom, H., Guchelaar, H. J., van der Hoeven, J. J., Links, T. P., Kapiteijn, E., van Erp, N. P.
Published in Cancer chemotherapy and pharmacology (01.07.2016)
Published in Cancer chemotherapy and pharmacology (01.07.2016)
Get full text
Journal Article
Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs
Overbeek, J.K., ter Heine, R., Verheul, H.M.W., Chatelut, E., Rudek, M.A., Gurney, H., Plummer, R., Gilbert, D.C., Buclin, T., Burger, D.M., Bloemendal, H.J., van Erp, N.P.
Published in ESMO open (01.02.2023)
Published in ESMO open (01.02.2023)
Get full text
Journal Article
Sunitinib for the treatment of metastatic gastrointestinal stromal tumors: the effect of TDM-guided dose optimization on clinical outcomes
Giraud, E.L., Westerdijk, K., van der Kleij, M.B.A., Guchelaar, N.A.D., Meertens, M., Bleckman, R.F., Rieborn, A., Mohammadi, M., Roets, E., Mathijssen, R.H.J., Huitema, A.D.R., Koolen, S.L.W., Gelderblom, H., Moes, D.J.A.R., Reyners, A.K.L., Touw, D.J., Keizer-Heldens, P., Oosten, A.W., van der Graaf, W.T.A., Steeghs, N., van Erp, N.P., Desar, I.M.E.
Published in ESMO open (01.06.2024)
Published in ESMO open (01.06.2024)
Get full text
Journal Article
Imatinib, sunitinib and pazopanib: From flat‐fixed dosing towards a pharmacokinetically guided personalized dose
Westerdijk, Kim, Desar, Ingrid M.E., Steeghs, Neeltje, Graaf, Winette T.A., Erp, Nielka P.
Published in British journal of clinical pharmacology (01.02.2020)
Published in British journal of clinical pharmacology (01.02.2020)
Get full text
Journal Article
442OTherapeutic drug monitoring of oral anticancer drugs - preliminary results of a prospective study
Groenland, S L, Van Eerden, R A G, Koolen, S L, Moes, D J A R, Desar, I M E, Touw, D J, Imholz, A L T, Reyners, A K L, Gelderblom, H, van Erp, N P, Mathijssen, R H J, Huitema, A D R, Steeghs, N
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
The influence of old age on everolimus exposure in patients with cancer
Willemsen, A.E.C.A.B., van Herpen, C., Schneider, T.C., de Wit, D., Kapiteijn, E., van Erp, N.P.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib
Lankheet, N., Desar, I.M., Mulder, S.F., Burger, D.M., van Herpen, C.M.L., van der Graaf, W.T.A., van Erp, N.P.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer
Fonseca, Nicolette M., Maurice-Dror, Corinne, Herberts, Cameron, Tu, Wilson, Fan, William, Murtha, Andrew J., Kollmannsberger, Catarina, Kwan, Edmond M., Parekh, Karan, Schönlau, Elena, Bernales, Cecily Q., Donnellan, Gráinne, Ng, Sarah W. S., Sumiyoshi, Takayuki, Vergidis, Joanna, Noonan, Krista, Finch, Daygen L., Zulfiqar, Muhammad, Miller, Stacy, Parimi, Sunil, Lavoie, Jean-Michel, Hardy, Edward, Soleimani, Maryam, Nappi, Lucia, Eigl, Bernhard J., Kollmannsberger, Christian, Taavitsainen, Sinja, Nykter, Matti, Tolmeijer, Sofie H., Boerrigter, Emmy, Mehra, Niven, van Erp, Nielka P., De Laere, Bram, Lindberg, Johan, Grönberg, Henrik, Khalaf, Daniel J., Annala, Matti, Chi, Kim N., Wyatt, Alexander W.
Published in Nature communications (28.02.2024)
Published in Nature communications (28.02.2024)
Get full text
Journal Article
The Combination of Enzalutamide and Opioids: A Painful Pitfall?
Benoist, Guillemette E., van Oort, Inge M., Burger, David M., Koch, Birgit C.P., Mehra, Niven, van Erp, Nielka P.
Published in European urology (01.02.2019)
Published in European urology (01.02.2019)
Get full text
Journal Article
Effect of smoking on imatinib pharmacokinetics
van Erp, N. P., Gelderblom, H., van Glabbeke, M., van Oosterom, A., Verweij, J., Guchelaar, H., Peng, B., Judson, I.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article